Paper36061533
Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review.
Jia Y and 5 others. Front Cardiovasc Med, 2022. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review. Papers, record 36061533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36061533
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34685620 | BMP-7 Attenuates Inflammation-Induced Pyroptosis and Improves Cardiac Repair in Diabetic Cardiomyopathy. | Cells | 2021 | https://conductscience.org/library/papers/34685620 | PubMed |
| 2 | 29993180 | Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/29993180 | PubMed |
| 3 | 28367225 | Total Coumarins from Hydrangea paniculata Protect against Cisplatin-Induced Acute Kidney Damage in Mice by Suppressing Renal Inflammation and Apoptosis. | Evid Based Complement Alternat Med | 2017 | https://conductscience.org/library/papers/28367225 | PubMed |
| 4 | 30710997 | SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. | Cardiovasc Diabetol | 2019 | https://conductscience.org/library/papers/30710997 | PubMed |
| 5 | 30039249 | SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice. | Diabetes Ther | 2018 | https://conductscience.org/library/papers/30039249 | PubMed |
| 6 | 34227220 | Association between prediabetes and adverse outcomes in heart failure. | Diabetes Obes Metab | 2021 | https://conductscience.org/library/papers/34227220 | PubMed |
| 7 | 11303500 | Pro-inflammatory programmed cell death. | Trends Microbiol | 2001 | https://conductscience.org/library/papers/11303500 | PubMed |
| 8 | 35620334 | Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes. | Adv Pharm Bull | 2022 | https://conductscience.org/library/papers/35620334 | PubMed |
| 9 | 28503425 | Neuroprotective effects of gypenosides in experimental autoimmune optic neuritis. | Int J Ophthalmol | 2017 | https://conductscience.org/library/papers/28503425 | PubMed |
| 10 | 30538469 | Potential effects of different natural antioxidants on inflammatory damage and oxidative-mediated hepatotoxicity induced by gold nanoparticles. | Int J Nanomedicine | 2018 | https://conductscience.org/library/papers/30538469 | PubMed |
| 11 | 29264825 | Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. | Mol Cell Biochem | 2018 | https://conductscience.org/library/papers/29264825 | PubMed |
| 12 | 33084415 | Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis. | Autoimmunity | 2020 | https://conductscience.org/library/papers/33084415 | PubMed |
| 13 | 26406389 | Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. | Can J Physiol Pharmacol | 2015 | https://conductscience.org/library/papers/26406389 | PubMed |
| 14 | 18332268 | Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy. | Circulation | 2008 | https://conductscience.org/library/papers/18332268 | PubMed |
| 15 | 30035063 | Bone morphogenetic protein-7: Review of signalling and efficacy in fracture healing. | J Orthop Translat | 2016 | https://conductscience.org/library/papers/30035063 | PubMed |
| 16 | 28877690 | Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA. | BMC Complement Altern Med | 2017 | https://conductscience.org/library/papers/28877690 | PubMed |
| 17 | 11110769 | Myocardial cell death in human diabetes. | Circ Res | 2000 | https://conductscience.org/library/papers/11110769 | PubMed |
| 18 | 33525971 | Exploring the role of non-coding RNAs in autophagy. | Autophagy | 2022 | https://conductscience.org/library/papers/33525971 | PubMed |
| 19 | 31886288 | Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway. | J Diabetes Res | 2019 | https://conductscience.org/library/papers/31886288 | PubMed |
| 20 | 30415602 | Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30415602 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42801360 | Rosiglitazone alleviates white matter injury by inhibiting NLRP3/capspase-1 mediated microglial pyroptosis via downregulating KLF4. | Exp Brain Res | 2026 | https://conductscience.org/library/papers/42801360 | PubMed |
| 42374512 | Global research trends of cell death in diabetic cardiomyopathy from 2000 to 2024: a bibliometric analysis and integrative overview. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42374512 | PubMed |
| 42238639 | Pyroptosis: Novel Targets in Molecular Mechanisms and Drug Therapy Research for Myocardial Ischemia Reperfusion Injury. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42238639 | PubMed |
| 40022088 | Non-coding RNAs affecting NLRP3 inflammasome pathway in diabetic cardiomyopathy: a comprehensive review of potential therapeutic options. | J Transl Med | 2025 | https://conductscience.org/library/papers/40022088 | PubMed |
| 39125850 | Molecular Basis of Cardiomyopathies in Type 2 Diabetes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125850 | PubMed |
| 38321349 | Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death. | Cardiovasc Toxicol | 2024 | https://conductscience.org/library/papers/38321349 | PubMed |
| 37124222 | Hydrogen sulfide plays an important role by regulating endoplasmic reticulum stress in myocardial diseases. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37124222 | PubMed |
| 36517746 | Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes. | BMC Mol Cell Biol | 2022 | https://conductscience.org/library/papers/36517746 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36061533
GET https://conductscience.org/api/papers/v1/36061533/references?page=2